Madrigal Stock Performance

MDGL
 Stock
  

USD 80.16  7.04  9.63%   

On a scale of 0 to 100, Madrigal Pharmaceuticals holds a performance score of 6. The company secures a Beta (Market Risk) of 1.2546, which conveys a somewhat significant risk relative to the market. Let's try to break down what Madrigal's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Madrigal Pharmaceuticals will likely underperform. Although it is vital to follow Madrigal Pharmaceuticals price patterns, it is good to be conservative about what you can do with the information regarding equity historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Madrigal Pharmaceuticals technical indicators, you can presently evaluate if the expected return of 0.38% will be sustainable into the future. Please exercises Madrigal Pharmaceuticals information ratio, downside variance, day median price, as well as the relationship between the treynor ratio and kurtosis to make a quick decision on whether Madrigal Pharmaceuticals current price movements will revert.
  
Madrigal Performance
6 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak technical and fundamental indicators, Madrigal Pharmaceuticals revealed solid returns over the last few months and may actually be approaching a breakup point. ...more

Structure and Payout Changes

Last Split Factor
1:35
Dividend Date
2016-07-25
Last Split Date
2016-07-25

Madrigal Price Channel

Begin Period Cash Flow54004000.00
Total Cashflows From Investing Activities-5055000.00

Madrigal Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  6,642  in Madrigal Pharmaceuticals on September 5, 2022 and sell it today you would earn a total of  1,374  from holding Madrigal Pharmaceuticals or generate 20.69% return on investment over 90 days. Madrigal Pharmaceuticals is currently generating 0.3789% in daily expected returns and assumes 4.2605% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than Madrigal, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.34 times more return on investment than the market. However, the company is 2.96 times less risky than the market. It trades about 0.09 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly -0.11 per unit of risk.

Madrigal Pharmaceuticals Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Madrigal Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Madrigal Pharmaceuticals, and traders can use it to determine the average amount a Madrigal Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0889

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsMDGL
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 4.26
  actual daily
 
 37 %
of total potential
 
3737
Expected Return
 0.38
  actual daily
 
 7 %
of total potential
 
77
Risk-Adjusted Return
 0.09
  actual daily
 
 6 %
of total potential
 
66
Based on monthly moving average Madrigal Pharmaceuticals is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Madrigal Pharmaceuticals by adding it to a well-diversified portfolio.

About Madrigal Pharmaceuticals Performance

To evaluate Madrigal Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Madrigal Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Madrigal Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Madrigal Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Madrigal's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Investment(92.26) (99.55) 
Return on Average Assets(86.32) (93.14) 
Return on Average Equity(110.92) (119.67) 
Return on Invested Capital(1.20) (1.30) 
Return on Sales(373.11) (382.93) 

Things to note about Madrigal Pharmaceuticals

Checking the ongoing alerts about Madrigal Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Madrigal Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Madrigal Pharmaceuticals Alerts

Equity Alerts and Improvement Suggestions

Madrigal Pharmaceuticals has very high historical volatility over the last 90 days
The company reported the previous year's revenue of 37.32 K. Net Loss for the year was (241.85 M) with profit before overhead, payroll, taxes, and interest of 0.
Madrigal Pharmaceuticals currently holds about 211.77 M in cash with (183.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.38.
Madrigal Pharmaceuticals has a frail financial position based on the latest SEC disclosures
Over 78.0% of the company shares are owned by institutional investors
Additionally, see Correlation Analysis. Note that the Madrigal Pharmaceuticals information on this page should be used as a complementary analysis to other Madrigal Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Madrigal Stock analysis

When running Madrigal Pharmaceuticals price analysis, check to measure Madrigal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Madrigal Pharmaceuticals is operating at the current time. Most of Madrigal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Madrigal Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Madrigal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Madrigal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Is Madrigal Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.4 B
Return On Assets
(0.74) 
Return On Equity
(2.23) 
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Madrigal Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.